Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,942,553
-
Share change
-
-3,251,180
-
Total reported value
-
$1,484,032,429
-
Put/Call ratio
-
106%
-
Price per share
-
$99.33
-
Number of holders
-
89
-
Value change
-
-$314,176,816
-
Number of buys
-
38
-
Number of sells
-
49
Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) as of Q2 2018
As of 30 Jun 2018 CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) had 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,942,553 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, BAILLIE GIFFORD & CO, Temasek Holdings (Private) Ltd, York Capital Management Global Advisors, LLC, VANGUARD GROUP INC, HSBC HOLDINGS PLC, BANK OF AMERICA CORP /DE/, Hillhouse Capital Management, Ltd., FIL Ltd, and BlackRock Inc..
This table shows 89 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.